Gong C - Search Results

1

Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer.

Zhong W, Yang Y, Zhang A, Lin W, Liang G, Ling Y, Zhong J, Yong J, Liu Z, Tian Z, Lin Q, Luo Q, Li Y, Gong C. Zhong W, et al. Among authors: gong c. Breast Cancer. 2020 Nov;27(6):1147-1157. doi: 10.1007/s12282-020-01142-8. Epub 2020 Aug 11. Breast Cancer. 2020. PMID: 32780321

2

Ubc9 expression predicts chemoresistance in breast cancer.

Chen SF, Gong C, Luo M, Yao HR, Zeng YJ, Su FX. Chen SF, et al. Among authors: gong c. Chin J Cancer. 2011 Sep;30(9):638-44. doi: 10.5732/cjc.011.10084. Chin J Cancer. 2011. PMID: 21880185 Free PMC article.

3

Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy.

Zhao R, Wu J, Jia W, Gong C, Yu F, Ren Z, Chen K, He J, Su F. Zhao R, et al. Among authors: gong c. Onkologie. 2011;34(12):675-80. doi: 10.1159/000334552. Epub 2011 Nov 23. Onkologie. 2011. PMID: 22156446

4

Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival.

Nie Y, Liu X, Qu S, Song E, Zou H, Gong C. Nie Y, et al. Among authors: gong c. Cancer Sci. 2013 Apr;104(4):458-64. doi: 10.1111/cas.12092. Epub 2013 Jan 30. Cancer Sci. 2013. PMID: 23281836 Free PMC article.

5

Preoperative CA 15-3 levels predict the prognosis of nonmetastatic luminal A breast cancer.

Li H, Chen K, Su F, Song E, Gong C. Li H, et al. Among authors: gong c. J Surg Res. 2014 Jun 1;189(1):48-56. doi: 10.1016/j.jss.2014.02.048. Epub 2014 Mar 2. J Surg Res. 2014. PMID: 24680287

6

Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.

Tan W, Li Q, Chen K, Su F, Song E, Gong C. Tan W, et al. Among authors: gong c. Oncotarget. 2016 Mar 1;7(9):10373-85. doi: 10.18632/oncotarget.7219. Oncotarget. 2016. PMID: 26863572 Free PMC article. Review.

7

Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.

Chen Y, Chen K, Xiao X, Nie Y, Qu S, Gong C, Su F, Song E. Chen Y, et al. Among authors: gong c. BMC Cancer. 2016 May 19;16:320. doi: 10.1186/s12885-016-2352-8. BMC Cancer. 2016. PMID: 27198767 Free PMC article.

8

Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.

Gong C, Tan W, Chen K, You N, Zhu S, Liang G, Xie X, Li Q, Zeng Y, Ouyang N, Li Z, Zeng M, Zhuang S, Lau WY, Liu Q, Yin D, Wang X, Su F, Song E. Gong C, et al. EBioMedicine. 2016 Sep;11:199-209. doi: 10.1016/j.ebiom.2016.08.016. Epub 2016 Aug 17. EBioMedicine. 2016. PMID: 27566954 Free PMC article.

9

A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer.

Tan W, Luo W, Jia W, Liang G, Xie X, Zheng W, Song E, Su F, Gong C. Tan W, et al. Among authors: gong c. Oncotarget. 2016 Dec 27;7(52):87312-87322. doi: 10.18632/oncotarget.13549. Oncotarget. 2016. PMID: 27894097 Free PMC article.

10

Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer.

Alexander PB, Chen R, Gong C, Yuan L, Jasper JS, Ding Y, Markowitz GJ, Yang P, Xu X, McDonnell DP, Song E, Wang XF. Alexander PB, et al. Among authors: gong c. J Biol Chem. 2017 Jan 13;292(2):748-759. doi: 10.1074/jbc.M116.754960. Epub 2016 Nov 30. J Biol Chem. 2017. PMID: 27903634 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,493 results

Search Page

Filters